223 related articles for article (PubMed ID: 18715952)
1. Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.
Baryawno N; Sveinbjörnsson B; Eksborg S; Orrego A; Segerström L; Oqvist CO; Holm S; Gustavsson B; Kågedal B; Kogner P; Johnsen JI
Neuro Oncol; 2008 Oct; 10(5):661-74. PubMed ID: 18715952
[TBL] [Abstract][Full Text] [Related]
2. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy.
Inada T; Arai K; Kawamura M; Hatanaka K; Sato Y; Noshiro M; Harada Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):860-70. PubMed ID: 19726696
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
6. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription.
Subbaramaiah K; Benezra R; Hudis C; Dannenberg AJ
J Biol Chem; 2008 Dec; 283(49):33955-68. PubMed ID: 18842581
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases.
Rösch S; Ramer R; Brune K; Hinz B
Biochem Biophys Res Commun; 2005 Dec; 338(2):1171-8. PubMed ID: 16256948
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
11. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
Jin J; Chang Y; Wei W; He YF; Hu SS; Wang D; Wu YJ
Acta Pharmacol Sin; 2012 May; 33(5):701-9. PubMed ID: 22555372
[TBL] [Abstract][Full Text] [Related]
12. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.
Frölich S; Olliges A; Kern N; Schreiber Y; Narumiya S; Nüsing RM
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F209-19. PubMed ID: 22573380
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; West KA; Regan JW
J Biol Chem; 2002 Jan; 277(4):2614-9. PubMed ID: 11706038
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.
Takahashi HK; Liu K; Wake H; Mori S; Zhang J; Liu R; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2009 Nov; 331(2):656-70. PubMed ID: 19700629
[TBL] [Abstract][Full Text] [Related]
17. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis.
Shoda J; Ueda T; Kawamoto T; Todoroki T; Asano T; Sugimoto Y; Ichikawa A; Maruyama T; Nimura Y; Tanaka N
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):285-96. PubMed ID: 15017670
[TBL] [Abstract][Full Text] [Related]
19. Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.
Asano T; Shoda J; Ueda T; Kawamoto T; Todoroki T; Shimonishi M; Tanabe T; Sugimoto Y; Ichikawa A; Mutoh M; Tanaka N; Miwa M
Clin Cancer Res; 2002 Apr; 8(4):1157-67. PubMed ID: 11948128
[TBL] [Abstract][Full Text] [Related]
20. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
